Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NordCAN: Cannabidiol for hand osteoarthritis and psoriatic arthritis
2017-003574-13Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hand osteoarthritis and psoriatic arthritis (PsA) comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Change in VAS pain at 12 weeks. Started Mar 2018; status: completed.
02
Drugs
cannabidiol
03
Conditions
hand osteoarthritispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2017-003574-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003574-13.